Strategies for dosing and switching antipsychotics for optimal clinical management.

作者: Peter F. Buckley , Christoph U. Correll

DOI:

关键词:

摘要: Optimal clinical management of schizophrenia and bipolar disorder can be achieved through careful antipsychotic dosing and, if necessary, switching to another well-chosen using suitable strategies. For severely ill patients treated in practice, adequate may not result from following the relatively low levels abrupt titration schedules typically used registration trials. Data recent effectiveness trials, naturalistic studies, Roadmap Expert Consensus Survey provide evidence specific dose for agents that appropriate practice. Discontinuation frequent medication are common among with antipsychotics, but data suggest an trial first should undertaken before medication. Making a decision switch typical atypical or between antipsychotics involve consideration variables relating patient, illness, medication, patient's environment. Switching improve efficacy tolerability also predictable side effects withdrawal symptoms, including weight gain metabolic as well associated prolactin changes. Many occur during attributable receptor profiles antimuscarinic antihistaminic blockade. Individualized strategies include choice dose, tapering schedules; symptoms; patient psychoeducation reduce treat effects, increasing likelihood successful greater adherence efficacy.

参考文章(51)
Jose de Leon, Margaret T. Susce, Elaina Murray-Carmichael, The AmpliChip™ CYP450 Genotyping Test Molecular Diagnosis & Therapy. ,vol. 10, pp. 135- 151 ,(2006) , 10.1007/BF03256453
Tim J. Lambert, Switching antipsychotic therapy: what to expect and clinical strategies for improving therapeutic outcomes. The Journal of Clinical Psychiatry. ,vol. 68, pp. 10- 13 ,(2007)
Eugenio Aguglia, Maurizio De Vanna, Maria Luisa Onor, Domenico Ferrara, Insight in persons with schizophrenia Progress in Neuro-Psychopharmacology and Biological Psychiatry. ,vol. 26, pp. 1229- 1233 ,(2002) , 10.1016/S0278-5846(02)00242-7
Peter J. Weiden, Discontinuing and switching antipsychotic medications: understanding the CATIE schizophrenia trial. The Journal of Clinical Psychiatry. ,vol. 68, pp. 12- 19 ,(2007)
Tetsuro Ohmori, Ichiro Kawamura, Yasuhiro Kaneda, Akira Fujii, Impact of a switch from typical to atypical antipsychotic drugs on quality of life and gonadal hormones in male patients with schizophrenia. Neuro endocrinology letters. ,vol. 25, pp. 135- 140 ,(2004)
Darlene Jody, Robert D. McQuade, William H. Carson, Elyse Stock, Ron Marcus, Don Archibald, Simon Vanveggel, Neveen A. Gharbia, A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study. The Journal of Clinical Psychiatry. ,vol. 65, pp. 47- 56 ,(2004)
PETER J. WEIDEN, EPS profiles: the atypical antipsychotics are not all the same. Journal of Psychiatric Practice. ,vol. 13, pp. 13- 24 ,(2007) , 10.1097/00131746-200701000-00003
José Manuel Montes, Jose Luis Rodriguez, Eduardo Balbo, Pedro Sopelana, Eloy Martin, Jose Antonio Soto, Jose Francisco Delgado, Teresa Diez, Inmaculada Villardaga, Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidone. Progress in Neuro-psychopharmacology & Biological Psychiatry. ,vol. 31, pp. 383- 388 ,(2007) , 10.1016/J.PNPBP.2006.10.002
Deborah A. O'Donnell, Paramjit T. Joshi, Shulamit M. Lewin, Innovations: Child & Adolescent Psychiatry Training in Developmental Responses to Trauma for Child Service Providers Psychiatric Services. ,vol. 58, pp. 12- 14 ,(2007) , 10.1176/PS.2007.58.1.12
Richard R. Owen, Ellen P. Fischer, JoAnn E. Kirchner, Carol R. Thrush, D. Keith Williams, Brian J. Cuffel, Carl E. Elliott, Brenda M. Booth, Clinical practice variations in prescribing antipsychotics for patients with schizophrenia. American Journal of Medical Quality. ,vol. 18, pp. 140- 146 ,(2003) , 10.1177/106286060301800402